Medindia LOGIN REGISTER
Medindia
Advertisement

Pipeline Insight: Small Molecule Targeted Cancer Therapies - New Targets Set to Drive Growth Now Available on ReportsandReports

Tuesday, April 20, 2010 Cancer News
Advertisement
DALLAS, April 20, 2010

- ReportsandReports Announce it Will Carry Pipeline Insight: SmallMolecule Targeted Cancer Therapies - New targets set to drive growth MarketResearch Report in its Store.
Advertisement

Browse the complete Report on:http://www.reportsandreports.com/market-reports/pipeline-insight-small-molecule-targeted-cancer-therapies-new-/

(Due to the length of this URL, it may be necessary to copy and pastethis hyperlink into your Internet browser's URL address field. Remove thespace if one exists.)
Advertisement

Small molecule targeted therapies represent a highly lucrative class ofanticancer therapies with 12 drugs currently approved for various tumortypes. This promise of high commercial rewards has driven considerablepipeline activity for small molecule targeted therapies within cancer.

Highlights

There are currently 288 small molecule targeted therapies in developmentfor cancer. Single-target signal transduction inhibitors and multi-targetedinhibitors form the majority of the pipeline, accounting for 28% and 28% ofthe pipeline, respectively. These two classes each contain a number of agentswith novel mechanisms of action.

Progress in understanding of how to target tyrosine kinases with smallmolecules has benefited oncology drug discovery. Efforts are continuing todevelop small molecule inhibitors against other kinases that are moreselective and capable of overcoming drug resistance. Around 30 distincttargets are currently being tested in Phase I clinical trials.

The late-phase small molecule therapies directed towards novel targetsare forecast to generate sales of $3,635m by 2019 across the seven majormarkets. Abiraterone (Cougar Biotechnology/Johnson & Johnson) and BSI-201(BiPar Sciences/Sanofi-Aventis) are forecast to achieve the highest sales by2019.

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depthmarket research studies of over 5000 micro markets, and 25 industry specificwebsites. Our client list boasts almost all well-known publishers of suchreports across the globe. We as a third-party reseller of market researchreports employ a number of marketing tools, such as press releases,email-marketing and effective search-engine optimization techniques to driverevenues for our clients. We also provide 24/7 online and offline supportservice to our customers.Scope - Examination of the small molecule targeted cancer therapies pipeline with in-depth clinical and commercial profiles of Phase III candidates - Seven major pharmaceutical market sales forecasts for Phase III pipeline products through to 2019 with product-specific assumptions - Segmentation and analysis of the current small molecule targeted cancer therapies pipeline by developmental phase, drug target and company - Insight and analysis of market potential including commercial opportunity and discussion of unmet needs

SOURCE Markets and Markets
Sponsored Post and Backlink Submission


Latest Press Release on Cancer News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close